Arcadia Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Arcadia Biosciences (RKDA).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$6Upside to Avg. PT+4131.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 21, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$6
May 23, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$10→$6
Apr 5, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $6 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Arcadia Biosciences (NASDAQ:RKDA) with a Buy and maintains $6 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $6

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and lowers the price target from $10 to $6.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $10 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Arcadia Biosciences (NASDAQ:RKDA) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $10

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and lowers the price target from $15 to $10.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $15 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Arcadia Biosciences (NASDAQ:RKDA) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $15

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and lowers the price target from $18 to $15.

Benzinga Newsdesk

Arcadia Biosciences Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Arcadia Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $6 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $6

PRO
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $10 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $10

PRO
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $15 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $15

People Also Watch

People Also Watch

Arcadia Biosciences Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Arcadia Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $6 Price Target

PROHC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $6

PROHC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $10 Price Target

PROHC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $10

PROHC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $15 Price Target

PROHC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $15

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $6 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $6

PRO
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $10 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $10

PRO
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $15 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $15